Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Kintara Therapeutics, Inc. (DMPI)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 | Jun-30-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -2774.7% | | | | -50587.9% | -11662.2% | | -4160.7% |
| ROIC (including intangibles) | -2749.2% | -5065.6% | 345.7% | -523.2% | 4715.3% | -2542.6% | 3199.0% | -8899.0% |
| ROE | -178.8% | -360.4% | -2641.1% | 416.2% | -205.7% | -135.3% | -79.7% | 602.6% |
| ROA | -132.2% | -281.6% | -236.4% | 202.9% | -158.0% | -112.5% | -60.9% | -192.2% |
| |
| Cash Conversion Cycle |
| Days payables outstanding | | | | | | | | |
|